Methods and compositions using non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of hiv
AssigneeThe Wistar Institute of Anatomy and Biology
InventorMohamed Abdel-Mohsen
Life of this patent
Estimating the term…
Abstract
Methods and compositions are provided for the non-invasive diagnosis of likelihood of HIV remission after antiretroviral therapy (ART) interruption, prediction of time-to-viral-rebound in an HIV subject after ART interruption and prediction of the probability of viral rebound in an HIV subject after ART interruption. Methods for treating HIV subjects by increasing or decreasing expression of certain metabolites or glycans are also provided.
Claims19
A diagnostic kit for the non-invasive prediction of time-to-viral-rebound in an HIV subject after antiretroviral therapy (ART) interruption comprising reagents that detect and measure the metabolites and glycans comprising:
- (a) Plasma A3G3S3 glycans, Pyruvic acid, Plasma T-antigen that binds the lectic MPA, Plasma T-antigen that binds the lectin ACA, Total fucose, L-glutamic acid, and (GlcNAc)n;
- or
- (b) IgG A2 glycans, Plasma A3G3S3 glycans, Total Fucose, Core fucose, Plasma T-antigen that binds lectin ABA, (GlcNAc)n, and L-glutamic acid.
(canceled)
A method for predicting time-to-viral rebound in an HIV-infected subject's sample, comprising detecting and measuring the levels of the combination of metabolites and glycans comprising:
- (a) Plasma A3G3S3 glycans, Pyruvic acid, Plasma T-antigen that binds the lectic MPA, Plasma T-antigen that binds the lectin ACA, Total fucose, L-glutamic acid, and (GlcNAc)n;
- or
- (b) IgG A2 glycans, Plasma A3G3S3 glycans, Total Fucose, Core fucose, Plasma T-antigen that binds lectin ABA, (GlcNAc)n, and L-glutamic acid.
(canceled)
A method for treating an HIV-infected subject comprising increasing the in vivo level or expression of one of more of the metabolites and glycans selected from:
- (a) Glychocholic acid, Taurochenodeoxycholic acid, Glycoursodeoxycholic acid, D Glucose, Ethylmalonic acid, N-Acetyl glutamic acid, Malonic acid, Ethylmalonic acid, 1, 5, Anhydro D glucitol, Kojic acid, D-ribono-1,4-lactone, Gamma aminobutyric acid GABA, Oxoglutaric acid (α-ketoglutaric acid) and L-glutamic acid, or
- (b) Pyruvic acid, L-Lactic acid, Taurine, Glycerol-3-phosphate, Indole-3 lactic acid, Indole 3 pyruvic acid, Imidazole lactic acid, Glycerophospho-N-palmitoyl ethanolamine, 2-oxindole, 3-Indoxyl sulphate, Nicotinamide, and Trimethylamine N-oxide.
(canceled)
Dependencies are inferred from the claim text.